These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30317857)
1. Acute pancreatitis associated with indigo naturalis in pediatric severe Crohn's disease. Kim HA; Suh HR; Kang B; Choe BH; Intest Res; 2019 Jan; 17(1):144-148. PubMed ID: 30317857 [TBL] [Abstract][Full Text] [Related]
2. Indigo naturalis (Qing dai) for inflammatory bowel disease: A systematic review and meta-analysis. Kakdiya R; Jha DK; Choudhury A; Jena A; Sharma V Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102250. PubMed ID: 38006941 [TBL] [Abstract][Full Text] [Related]
3. Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report. Cho B; Yoon SM; Son SM; Kim HW; Kim KB; Youn SJ BMC Gastroenterol; 2020 May; 20(1):154. PubMed ID: 32414334 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis. Shimada F; Yoshimatsu Y; Sujino T; Fukuda T; Aoki Y; Hayashi Y; Tojo A; Kawaguchi T; Kiyohara H; Sugimoto S; Nanki K; Mikami Y; Miyamoto K; Takabayashi K; Hosoe N; Kato M; Ogata H; Naganuma M; Kanai T Sci Rep; 2024 Mar; 14(1):5778. PubMed ID: 38459203 [TBL] [Abstract][Full Text] [Related]
5. Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota. Sun Z; Li J; Dai Y; Wang W; Shi R; Wang Z; Ding P; Lu Q; Jiang H; Pei W; Zhao X; Guo Y; Liu J; Tan X; Mao T Front Microbiol; 2020; 11():731. PubMed ID: 32425906 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis. Wu D; Huang Q; Xu Y; Cao R; Yang M; Xie J; Zhang D J Ethnopharmacol; 2025 Jan; 337(Pt 1):118782. PubMed ID: 39236777 [TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term outcomes of indigo naturalis treatment for inflammatory bowel disease. Matsuno Y; Hirano A; Torisu T; Okamoto Y; Fuyuno Y; Fujioka S; Umeno J; Moriyama T; Nagai S; Hori Y; Fujiwara M; Kitazono T; Esaki M J Gastroenterol Hepatol; 2020 Mar; 35(3):412-417. PubMed ID: 31389626 [TBL] [Abstract][Full Text] [Related]
8. From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis. Qi-Yue Y; Ting Z; Ya-Nan H; Sheng-Jie H; Xuan D; Li H; Chun-Guang X Chin Med; 2020 Dec; 15(1):127. PubMed ID: 33317592 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis. Yokote A; Imazu N; Umeno J; Kawasaki K; Fujioka S; Fuyuno Y; Matsuno Y; Moriyama T; Miyawaki K; Akashi K; Kitazono T; Torisu T J Gastroenterol; 2023 Sep; 58(9):868-882. PubMed ID: 37410250 [TBL] [Abstract][Full Text] [Related]
10. Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey. Naganuma M; Sugimoto S; Suzuki H; Matsuno Y; Araki T; Shimizu H; Hayashi R; Fukuda T; Nakamoto N; Iijima H; Nakamura S; Kataoka M; Tamura Y; Tatsumi K; Hibi T; Suzuki Y; Kanai T; J Gastroenterol; 2019 Oct; 54(10):891-896. PubMed ID: 31102012 [TBL] [Abstract][Full Text] [Related]
11. Fast Inspection of Quality of Indigo Naturalis by Multiple Light Scattering. Liu X; Ye H; Huang H; Yang M; Han L; Xu R; Zhang D J Vis Exp; 2023 Aug; (198):. PubMed ID: 37607092 [TBL] [Abstract][Full Text] [Related]
12. Evidence and potential mechanism of action of indigo naturalis and its active components in the treatment of psoriasis. Wang C; Yang P; Wang J; Liu L; Chen J; Cai X; Zhang M; Lin N; Wang S; Yu Y; Li L; Li X Ann Med; 2024 Dec; 56(1):2329261. PubMed ID: 39316667 [TBL] [Abstract][Full Text] [Related]
13. Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community. Liang YN; Yu JG; Zhang DB; Zhang Z; Ren LL; Li LH; Wang Z; Tang ZS Molecules; 2019 Nov; 24(22):. PubMed ID: 31726738 [TBL] [Abstract][Full Text] [Related]
14. Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositis. Hirata K; Yamada Y; Hamamoto Y; Tsunoda K; Muramatsu H; Horie S; Sukawa Y; Naganuma M; Nakagawa T; Kanai T BMJ Support Palliat Care; 2024 Jan; 13(e3):e1001-e1007. PubMed ID: 34649840 [TBL] [Abstract][Full Text] [Related]
15. Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells. Chang HN; Huang ST; Yeh YC; Wang HS; Wang TH; Wu YH; Pang JH J Ethnopharmacol; 2015 Nov; 174():474-81. PubMed ID: 26341616 [TBL] [Abstract][Full Text] [Related]
17. [Challenges and strategies of high-quality development of Indigo Naturalis industry]. Yang M; Zhang DK; He YN; Han L; Wang F; Xu RC Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(13):3171-3179. PubMed ID: 34396734 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis. Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T; Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928 [TBL] [Abstract][Full Text] [Related]
19. Liquid Chromatography-Tandem Mass Spectrometry-Based Metabolomics Analysis of Fan A; Hou BL; Tang Z; Wang T; Zhang D; Liang Y; Wang Z J Med Food; 2023 Dec; 26(12):877-889. PubMed ID: 38010862 [TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis. Sun Q; Leng J; Tang L; Wang L; Fu C Front Pharmacol; 2021; 12():664022. PubMed ID: 34135755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]